A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy
Their approach starts with in-depth lab testing to understand your unique biology, from hormones to metabolic markers
Understanding Dosage and Quality When looking at a supplement label, you might see "L-Glutathione" or "Reduced Glutathione." This simply refers to the stable, active form of the molecule that is ready for the body to use
Scottish Intercollegiate Guideline Network (SIGN)
Oral metabolic franchise, a broader portfolio of oral small molecule candidates targeting metabolic disease beyond the lead GLP-1 program Recent Highlights: In May 2026, Structure reported positive end-of-Phase 2 feedback from the FDA for aleniglipron, clearing the way to begin a Phase 3 registrational program for chronic weight management in Q3 2026
Another trial demonstrated a significant reduction in body weight with the use of semaglutide, with subjects losing up to 14.9% of their initial body weight over a period of 68 weeks